Li, Yan BPharm, MS*; Liu, Wei MD, PhD*; Zhu, Yanmin BA*; Liu, Xinyue PhD*; Winterstein, Almut Gertrud PhD*†
From the *Department of Pharmaceutical Outcomes and Policy, College of Pharmacy; †Department of Epidemiology, College of Public Health and Health Professionals and College of Medicine, University of Florida, Gainesville, FL.
Received September 6, 2016; accepted after revision June 25, 2017.
Reprints: Yan Li, BPharm, MS, University of Florida, Gainesville, FL 32610 (e-mail: [email protected]).
This study was funded by the Florida Agency for Health Care Administration (Contract No. MED152).
This study was presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management on August 2015 in Boston, MA.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com).